|
Market Closed -
Euronext Paris
19:55:00 31/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.135 EUR | -2.13% |
|
+1.10% | +93.22% |
| 07-09 | THX Pharma secures its financial roadmap |  |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors | |
| Market Cap | 57.05M 66.26M 53.57M 48.9M 91.86M 6.3B 92.52M 635M 247M 3.2B 249M 243M 10.59B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 33.35M 38.73M 31.31M 28.58M 53.7M 3.69B 54.08M 371M 144M 1.87B 145M 142M 6.19B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.97% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.13% | ||
| 1 week | +1.10% | ||
| 1 month | -3.84% | ||
| 3 months | +10.56% | ||
| 6 months | +22.70% | ||
| Current year | +93.22% |
| 1 week | 4.11 |  | 4.36 |
| 1 month | 3.96 | | 4.75 |
| Current year | 1.83 | | 5.1 |
| 1 year | 1.49 | | 5.1 |
| 3 years | 0.26 | | 5.1 |
| 5 years | 0.26 | | 9.27 |
| 10 years | 0.26 | | 23.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/01/2023 | |
Christine Placet
DFI | Director of Finance/CFO | - | 01/04/2024 |
Marie Sebille
CTO | Chief Tech/Sci/R&D Officer | - | 19/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 31/03/2024 | |
| Chairman | - | 31/03/2024 | |
Julien Veys
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/04/26 | Buy | Chief Operating Officer | 2,825 | 0.0195% | ||
| 03/04/26 | Buy | Chief Operating Officer | 4,488 | 0.0310% | ||
| 03/04/26 | Sell | Chief Operating Officer | 4,944 | 0.0342% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13% | +1.10% | +60.89% | +248.65% | 67.65M | |
| -1.66% | -4.96% | +49.84% | +88.43% | 69.54B | |
| -2.19% | +1.32% | +44.54% | +88.38% | 64.97B | |
| +1.68% | +2.18% | +38.02% | +12.48% | 26.51B | |
| +2.77% | -1.74% | -16.16% | +456.51% | 25.89B | |
| -0.46% | -9.94% | +0.98% | -15.98% | 25.64B | |
| -9.71% | -0.36% | +245.87% | +377.68% | 20.22B | |
| -1.58% | +0.47% | +29.35% | -19.62% | 19.98B | |
| -3.26% | -8.03% | -1.03% | +528.76% | 15.69B | |
| +0.35% | +0.16% | +46.96% | +144.04% | 13.49B | |
| Average | -1.62% | -2.67% | +49.93% | +190.93% | 28.2B | |
| Weighted average by Cap. | -1.52% | -2.68% | +46.64% | +145.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 11.9M 13.82M 11.17M 10.2M 19.16M 1.32B 19.3M 132M 51.52M 667M 51.89M 50.77M 2.21B | 4.3M 4.99M 4.04M 3.69M 6.92M 475M 6.97M 47.84M 18.61M 241M 18.75M 18.34M 798M |
| Net Debt | -23.7M -27.53M -22.25M -20.31M -38.16M -2.62B -38.43M -264M -103M -1.33B -103M -101M -4.4B | -27.4M -31.82M -25.73M -23.49M -44.12M -3.03B -44.44M -305M -119M -1.54B -119M -117M -5.08B |
Employees
12
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/08/26 | €4.135 | -2.13% | 43,882 |
| 28/08/26 | €4.225 | +2.30% | 72,403 |
| 27/08/26 | €4.130 | -2.36% | 38,196 |
| 26/08/26 | €4.230 | +1.32% | 100,631 |
| 25/08/26 | €4.175 | +2.08% | 15,258 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.135EUR
Average target price
5.800EUR
Spread / Average Target
+40.27%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHX Stock
Select your edition
All financial news and data tailored to specific country editions
